Cherry Tree Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.2K Sell
160
-460
-74% -$53.1K ﹤0.01% 358
2025
Q4
$65.3K Sell
620
-77
-11% -$7.23K 0.01% 249
2025
Q3
$58.5K Sell
697
-240
-26% -$19.8K 0.01% 248
2025
Q2
$74.2K Sell
937
-398
-30% -$31.6K 0.02% 234
2025
Q1
$120K Buy
1,335
+87
+7% +$8.12K 0.03% 197
2024
Q4
$124K Sell
1,248
-50
-4% -$5.16K 0.03% 190
2024
Q3
$147K Hold
1,298
0.03% 179
2024
Q2
$161K Buy
1,298
+67
+5% +$8.63K 0.04% 167
2024
Q1
$162K Sell
1,231
-52
-4% -$6.41K 0.04% 172
2023
Q4
$140K Buy
1,283
+1
+0.1% +$104 0.04% 168
2023
Q3
$132K Buy
1,282
+66
+5% +$7.11K 0.04% 166
2023
Q2
$140K Buy
+1,216
New +$138K 0.04% 164

Other funds holding MRK

Cherry Tree Wealth Management's MRK Position: Q1 2026 in Review

Cherry Tree Wealth Management reduced its Merck (MRK) stake by 74% in Q1 2026, selling an estimated $53.1K and leaving 160 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #358.

Cherry Tree Wealth Management first reported a position in MRK in Q2 2023 and has held it in 12 quarters since. The position peaked at $162K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cherry Tree Wealth Management held 160 shares of Merck worth $19.2K as of Q1 2026.
  • Cherry Tree Wealth Management sold 460 Merck shares in Q1 2026, an estimated $53.1K.
  • Merck made up ﹤0.01% of Cherry Tree Wealth Management's portfolio in Q1 2026, its #358 holding.
  • Cherry Tree Wealth Management first reported a position in Merck in Q2 2023 and has held it in 12 quarters since.
  • Cherry Tree Wealth Management's Merck position peaked at $162K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.